Walpar Nutritions Ltd.

WALPAR

Market Cap
₹56 Cr.
P/E
35.35

Walpar Nutritions Ltd.

About
Walpar Nutritions Limited specializes in the development, manufacturing, and commercialization of a wide range of Herbo-Nutraceutical products including sales, marketing, quality assurance, distributi… Read more
Walpar Nutritions Limited specializes in the development, manufacturing, and commercialization… Read more
Low
78
52W Range
High
154
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

4 No Data

Insufficient data to analyse

ROE
Latest
11.15%
3yr Average
6.55%
5yr Average
5.7%
Net Profit Margin
Latest
2.53%
3yr Average
1.88%
5yr Average
2.03%
ROCE
Latest
15.48%
3yr Average
10.2%
5yr Average
8.56%
Debt to Equity
Latest
0.59
3yr Average
0.71
5yr Average
0.92
Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Walpar Nutritions Ltd. Business

Walpar Nutritions Limited is a manufacturing company specializing in a wide range of Nutraceutical products for human and animal healthcare. They focus on developing, manufacturing, and marketing their own brand of products.

Walpar Nutritions major competitors are Vineet Laboratories, Cian Healthcare, Chandra Bhagat Pharm, Sandu Pharmaceutical, JFL Life Sciences, Vivo Bio Tech, Veerhealth Care.
Market Cap of Walpar Nutritions is ₹56 Crs.
While the median market cap of its peers are ₹55 Crs.

Walpar Nutritions seems to be less financially stable compared to its peers.
Altman Z score of Walpar Nutritions is 4.01 and is ranked 5 out of its 8 competitors.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
timeline Timeline